These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 27590157)

  • 1. Delivery of the Porcupine Inhibitor WNT974 in Mice.
    Zhang LS; Lum L
    Methods Mol Biol; 2016; 1481():111-7. PubMed ID: 27590157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potent in vivo lung cancer Wnt signaling inhibition via cyclodextrin-LGK974 inclusion complexes.
    Guimaraes PPG; Tan M; Tammela T; Wu K; Chung A; Oberli M; Wang K; Spektor R; Riley RS; Viana CTR; Jacks T; Langer R; Mitchell MJ
    J Control Release; 2018 Nov; 290():75-87. PubMed ID: 30290244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Porcupine Inhibitor LGK974 Downregulates the Wnt Signaling Pathway and Inhibits Clear Cell Renal Cell Carcinoma.
    Li J; Wu G; Xu Y; Li J; Ruan N; Chen Y; Zhang Q; Xia Q
    Biomed Res Int; 2020; 2020():2527643. PubMed ID: 32104684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Porcupine inhibitor LGK‑974 inhibits Wnt/β‑catenin signaling and modifies tumor‑associated macrophages resulting in inhibition of the malignant behaviors of non‑small cell lung cancer cells.
    Tang Y; Jiang M; Chen A; Qu W; Han X; Zuo J; Xu G; Song Y; Chen C; Ke X
    Mol Med Rep; 2021 Aug; 24(2):. PubMed ID: 34080032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Porcupine inhibitors: Novel and emerging anti-cancer therapeutics targeting the Wnt signaling pathway.
    Shah K; Panchal S; Patel B
    Pharmacol Res; 2021 May; 167():105532. PubMed ID: 33677106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting Wnt-driven cancer through the inhibition of Porcupine by LGK974.
    Liu J; Pan S; Hsieh MH; Ng N; Sun F; Wang T; Kasibhatla S; Schuller AG; Li AG; Cheng D; Li J; Tompkins C; Pferdekamper A; Steffy A; Cheng J; Kowal C; Phung V; Guo G; Wang Y; Graham MP; Flynn S; Brenner JC; Li C; Villarroel MC; Schultz PG; Wu X; McNamara P; Sellers WR; Petruzzelli L; Boral AL; Seidel HM; McLaughlin ME; Che J; Carey TE; Vanasse G; Harris JL
    Proc Natl Acad Sci U S A; 2013 Dec; 110(50):20224-9. PubMed ID: 24277854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Porcupine inhibitors impair trabecular and cortical bone mass and strength in mice.
    Funck-Brentano T; Nilsson KH; Brommage R; Henning P; Lerner UH; Koskela A; Tuukkanen J; Cohen-Solal M; Movérare-Skrtic S; Ohlsson C
    J Endocrinol; 2018 Jul; 238(1):13-23. PubMed ID: 29720540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FZD6 triggers Wnt-signalling driven by WNT10B
    Cassaro A; Grillo G; Notaro M; Gliozzo J; Esposito I; Reda G; Trojani A; Valentini G; Di Camillo B; Cairoli R; Beghini A
    Hematol Oncol; 2021 Aug; 39(3):364-379. PubMed ID: 33497493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemical Modulation of WNT Signaling in Cancer.
    Zhang LS; Lum L
    Prog Mol Biol Transl Sci; 2018 Jan; 153():245-269. PubMed ID: 29389519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploration of the linkage elements of porcupine antagonists led to potent Wnt signaling pathway inhibitors.
    Dong Y; Li K; Xu Z; Ma H; Zheng J; Hu Z; He S; Wu Y; Sun Z; Luo L; Li J; Zhang H; Zhang X
    Bioorg Med Chem; 2015 Nov; 23(21):6855-68. PubMed ID: 26455655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase 1 study of single-agent WNT974, a first-in-class Porcupine inhibitor, in patients with advanced solid tumours.
    Rodon J; Argilés G; Connolly RM; Vaishampayan U; de Jonge M; Garralda E; Giannakis M; Smith DC; Dobson JR; McLaughlin ME; Seroutou A; Ji Y; Morawiak J; Moody SE; Janku F
    Br J Cancer; 2021 Jul; 125(1):28-37. PubMed ID: 33941878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting the Wnt/β-catenin pathway in primary ovarian cancer with the porcupine inhibitor WNT974.
    Boone JD; Arend RC; Johnston BE; Cooper SJ; Gilchrist SA; Oelschlager DK; Grizzle WE; McGwin G; Gangrade A; Straughn JM; Buchsbaum DJ
    Lab Invest; 2016 Feb; 96(2):249-59. PubMed ID: 26658453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. WNT ligands control initiation and progression of human papillomavirus-driven squamous cell carcinoma.
    Zimmerli D; Cecconi V; Valenta T; Hausmann G; Cantù C; Restivo G; Hafner J; Basler K; van den Broek M
    Oncogene; 2018 Jul; 37(27):3753-3762. PubMed ID: 29662191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The porcupine inhibitor WNT974 provokes ectodermal lineage differentiation of human embryonic stem cells.
    Kalantary-Charvadeh A; Hosseini V; Mehdizadeh A; Nazari Soltan Ahmad S; Rahbarghazi R; Nozad Charoudeh H; Nouri M; Darabi M
    Cell Biochem Funct; 2022 Jun; 40(4):359-368. PubMed ID: 35445405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockade to pathological remodeling of infarcted heart tissue using a porcupine antagonist.
    Moon J; Zhou H; Zhang LS; Tan W; Liu Y; Zhang S; Morlock LK; Bao X; Palecek SP; Feng JQ; Williams NS; Amatruda JF; Olson EN; Bassel-Duby R; Lum L
    Proc Natl Acad Sci U S A; 2017 Feb; 114(7):1649-1654. PubMed ID: 28143939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An
    Asciolla JJ; Miele MM; Hendrickson RC; Resh MD
    J Biol Chem; 2017 Aug; 292(33):13507-13513. PubMed ID: 28655768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms and inhibition of Porcupine-mediated Wnt acylation.
    Liu Y; Qi X; Donnelly L; Elghobashi-Meinhardt N; Long T; Zhou RW; Sun Y; Wang B; Li X
    Nature; 2022 Jul; 607(7920):816-822. PubMed ID: 35831507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of Porcupine impairs convergent extension during gastrulation in zebrafish.
    Chen Q; Takada R; Takada S
    J Cell Sci; 2012 May; 125(Pt 9):2224-34. PubMed ID: 22357957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis, and evaluation of potent Wnt signaling inhibitors featuring a fused 3-ring system.
    Xu Z; Li J; Wu Y; Sun Z; Luo L; Hu Z; He S; Zheng J; Zhang H; Zhang X
    Eur J Med Chem; 2016 Jan; 108():154-165. PubMed ID: 26647303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel porcupine inhibitor blocks WNT pathways and attenuates cardiac hypertrophy.
    Jiang J; Lan C; Li L; Yang D; Xia X; Liao Q; Fu W; Chen X; An S; Wang WE; Zeng C
    Biochim Biophys Acta Mol Basis Dis; 2018 Oct; 1864(10):3459-3467. PubMed ID: 30076960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.